Cargando…
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
BACKGROUND: Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and improve population risk stratification, we aimed to id...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651931/ https://www.ncbi.nlm.nih.gov/pubmed/31337337 http://dx.doi.org/10.1186/s12860-019-0210-7 |
_version_ | 1783438459143192576 |
---|---|
author | Santaolalla, Aida Garmo, Hans Grigoriadis, Anita Ghuman, Sundeep Hammar, Niklas Jungner, Ingmar Walldius, Göran Lambe, Mats Holmberg, Lars Van Hemelrijck, Mieke |
author_facet | Santaolalla, Aida Garmo, Hans Grigoriadis, Anita Ghuman, Sundeep Hammar, Niklas Jungner, Ingmar Walldius, Göran Lambe, Mats Holmberg, Lars Van Hemelrijck, Mieke |
author_sort | Santaolalla, Aida |
collection | PubMed |
description | BACKGROUND: Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and improve population risk stratification, we aimed to identify metabolic profiles linked to carcinogenesis and mortality and their intrinsic associations by characterizing subgroups of individuals based on serum biomarker measurements. We included 13,615 participants from the Swedish Apolipoprotein MOrtality RISk Study who had measurements for 19 biomarkers representative of central metabolic pathways. Latent Class Analysis (LCA) was applied to characterise individuals based on their biomarker values (according to medical cut-offs), which were then examined as predictors of cancer and death using multivariable Cox proportional hazards models. RESULTS: LCA identified four metabolic profiles within the population: (1) normal values for all markers (63% of population); (2) abnormal values for lipids (22%); (3) abnormal values for liver functioning (9%); (4) abnormal values for iron and inflammation metabolism (6%). All metabolic profiles (classes 2–4) increased risk of cancer and mortality, compared to class 1 (e.g. HR for overall death was 1.26 (95% CI: 1.16–1.37), 1.67 (95% CI: 1.47–1.90), and 1.21 (95% CI: 1.05–1.41) for class 2, 3, and 4, respectively). CONCLUSION: We present an innovative approach to risk stratify a well-defined population based on LCA metabolic-defined subgroups for cancer and mortality. Our results indicate that standard of care baseline serum markers, when assembled into meaningful metabolic profiles, could help assess long term risk of disease and provide insight in disease susceptibility and etiology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12860-019-0210-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6651931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66519312019-07-31 Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis Santaolalla, Aida Garmo, Hans Grigoriadis, Anita Ghuman, Sundeep Hammar, Niklas Jungner, Ingmar Walldius, Göran Lambe, Mats Holmberg, Lars Van Hemelrijck, Mieke BMC Mol Cell Biol Research Article BACKGROUND: Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and improve population risk stratification, we aimed to identify metabolic profiles linked to carcinogenesis and mortality and their intrinsic associations by characterizing subgroups of individuals based on serum biomarker measurements. We included 13,615 participants from the Swedish Apolipoprotein MOrtality RISk Study who had measurements for 19 biomarkers representative of central metabolic pathways. Latent Class Analysis (LCA) was applied to characterise individuals based on their biomarker values (according to medical cut-offs), which were then examined as predictors of cancer and death using multivariable Cox proportional hazards models. RESULTS: LCA identified four metabolic profiles within the population: (1) normal values for all markers (63% of population); (2) abnormal values for lipids (22%); (3) abnormal values for liver functioning (9%); (4) abnormal values for iron and inflammation metabolism (6%). All metabolic profiles (classes 2–4) increased risk of cancer and mortality, compared to class 1 (e.g. HR for overall death was 1.26 (95% CI: 1.16–1.37), 1.67 (95% CI: 1.47–1.90), and 1.21 (95% CI: 1.05–1.41) for class 2, 3, and 4, respectively). CONCLUSION: We present an innovative approach to risk stratify a well-defined population based on LCA metabolic-defined subgroups for cancer and mortality. Our results indicate that standard of care baseline serum markers, when assembled into meaningful metabolic profiles, could help assess long term risk of disease and provide insight in disease susceptibility and etiology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12860-019-0210-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-23 /pmc/articles/PMC6651931/ /pubmed/31337337 http://dx.doi.org/10.1186/s12860-019-0210-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Santaolalla, Aida Garmo, Hans Grigoriadis, Anita Ghuman, Sundeep Hammar, Niklas Jungner, Ingmar Walldius, Göran Lambe, Mats Holmberg, Lars Van Hemelrijck, Mieke Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis |
title | Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis |
title_full | Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis |
title_fullStr | Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis |
title_full_unstemmed | Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis |
title_short | Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis |
title_sort | metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651931/ https://www.ncbi.nlm.nih.gov/pubmed/31337337 http://dx.doi.org/10.1186/s12860-019-0210-7 |
work_keys_str_mv | AT santaolallaaida metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT garmohans metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT grigoriadisanita metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT ghumansundeep metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT hammarniklas metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT jungneringmar metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT walldiusgoran metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT lambemats metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT holmberglars metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis AT vanhemelrijckmieke metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis |